In brief; Mayne Pharma have not met their guidance for several periods running and have written down a large chunk of their portfolio purchased using shareholders money from their last capital raising.
There are potential catalysts for growth but if you're looking for a safe entry into healthcare i'd look at something stable with long term prospects.
Ann: 2019 AGM CEO's Speech, page-175
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.38 |
Change
0.440(11.2%) |
Mkt cap ! $372.6M | |||
| Open | High | Low | Value | Volume |
| $4.40 | $4.79 | $4.18 | $2.649M | 590.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1271 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.44 | 1271 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |